Cited from NewYork Times. A unit of Johnson & Johnson said Monday that a jury has ordered Abbott Laboratories to pay $1.67 billion in a patent infringement suit over rheumatoid arthritis drugs. Abbott’s best-selling drug, Humira, competes with the drug Remicade, an arthritis treatment made by the Centocor unit of Johnson & Johnson. That company [...]
Filed under: Uncategorized | Tagged: patent infringement | 1 Comment »
